Cure My Disease

Don't miss your cure!

 Log in / Sign up

Digital tool aims to alert women to alcohol and breast cancer risk

NCT ID NCT07799467

Prevention Sponsor: University of Miami Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 02, 2026 · Last updated Sep 03, 2026 · Updated 1 time

Summary

Researchers are testing a digital program that educates women about the connection between alcohol and breast cancer risk. The study enrolls women aged 40 and older who drink alcohol regularly and are attending a routine breast cancer screening visit. Participants use the program during their visit and for four weeks afterward. The trial measures whether the program is practical, acceptable, and whether it increases women's knowledge and prompts changes in drinking behavior.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A digital behavioral intervention that includes alcohol screening, personalized feedback, education on alcohol-related breast cancer risk, motivational content, and goal-setting exercises.
What this could lead to
If it works, this digital tool could help women make more informed choices about alcohol and potentially lower their breast cancer risk.
What could go wrong
This is a small feasibility study, so it may not show clear changes in behavior or knowledge. The intervention's success depends on women finding it useful and engaging.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 36 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Women attending their screening visit * Regular alcohol users * Aged 40+ years * Fluent in English * With or without cancer * Not currently receiving cancer treatment * Own a smartphone, iPad, or computer * Able to provide consent * Must not have participated in Stage 1 or Stage 2. Exclusion Criteria: * Younger than 40 years * Non-English speaking * Unable to provide informed consent * Does not own a smartphone, iPad, or computer * Currently receiving cancer treatment * Prior participation in Stage 1 or Stage 2.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Alcohol drinking are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alcohol Drinking breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Alcohol drinking Breast cancer

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Don Soffer clinical research center

    Miami, Florida, 33136, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.